| 000 | 00877 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514040229.0 | ||
| 264 | 0 | _c20020730 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a1474-1776 | ||
| 024 | 7 |
_a10.1038/nrd709 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMilroy, David | |
| 245 | 0 | 0 |
_aAntiviral market overview. _h[electronic resource] |
| 260 |
_bNature reviews. Drug discovery _cJan 2002 |
||
| 300 |
_a11-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aFeatherstone, James | |
| 773 | 0 |
_tNature reviews. Drug discovery _gvol. 1 _gno. 1 _gp. 11-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrd709 _zAvailable from publisher's website |
| 999 |
_c12010588 _d12010588 |
||